← Back to home
Comparison · Analytics

GeneNMF vs medsim

A side-by-side editorial comparison of GeneNMF and medsim — release velocity, themes, recent moves, and the top alternatives to consider.

GeneNMF vs medsim: at a glance

FeatureGeneNMFmedsim
SectorAnalyticsAnalytics
Velocity score0.06.3
Sparks · 30d01
Top themessingle-cell-genomics, nmf, gene-programs, bioinformaticsmediation analysis, monte carlo, reproducibility, hpc
Last editorial update49m ago6h ago
WebsiteVisit →Visit →

What is GeneNMF?

GeneNMF rebuilt how it derives meta-programs, changing every result it had produced.

GeneNMF applies non-negative matrix factorization to single-cell expression data to find gene programs, then consolidates programs recurring across samples into meta-programs. Version 0.6.0 replaced the consolidation method: instead of reducing each program to a gene set and taking a consensus, it retains full gene weight vectors and compares them by cosine similarity. Later releases have built reporting and control around that core — a metaprogram composition matrix showing which samples contributed, custom signature databases for enrichment testing, and the ability to drop meta-programs from results.

Read the full GeneNMF trajectory →

What is medsim?

medsim is turning simulation runs into auditable artifacts, not just fast ones.

medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.

Read the full medsim trajectory →

GeneNMF vs medsim: editorial side-by-side

G
GeneNMF
ANALYTICS
0.0

GeneNMF rebuilt how it derives meta-programs, changing every result it had produced.

◆ Current state

GeneNMF applies non-negative matrix factorization to single-cell expression data to find gene programs, then consolidates programs recurring across samples into meta-programs. Version 0.6.0 replaced the consolidation method: instead of reducing each program to a gene set and taking a consensus, it retains full gene weight vectors and compares them by cosine similarity. Later releases have built reporting and control around that core — a metaprogram composition matrix showing which samples contributed, custom signature databases for enrichment testing, and the ability to drop meta-programs from results.

◆ Where it's heading

The package is moving from producing meta-programs to letting users interrogate and constrain how they were formed. Composition matrices, the drop function and downsampled similarity heatmaps all serve inspection rather than derivation. The parameters added alongside the 0.6.0 rewrite — specificity weighting, cumulative weight thresholds, confidence defined as the fraction of programs containing a gene — turn what were fixed internal choices into stated, tunable ones.

◆ Prediction

Recent releases have been fixes and compatibility work rather than method changes, so the core approach appears settled. The dependency on an RcppML version not on CRAN is the loose end most likely to force the next release.

M
medsim
ANALYTICS
6.3

medsim is turning simulation runs into auditable artifacts, not just fast ones.

◆ Current state

medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.

◆ Where it's heading

The arc is toward defensible HPC runs: each 0.5.x gate closes a way a cluster job could silently produce wrong output, and 0.5.1 extends the same suspicion to the estimator itself by exposing the branch disagreement the standard ARIV averages away. Releases are cadenced against discovered defects rather than a roadmap — 0.5.0 cites seven findings from a pre-integration review, and 0.5.1 cites an adversarial review of 0.5.0. The audit surface is widening faster than the method surface.

◆ Prediction

The collapse-audit exclusion list has now been patched twice for method-specific diagnostic columns, so the next likely move is a contract letting methods declare their own discrete fields instead of medsim naming them centrally.

Alternatives to GeneNMF and medsim

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either GeneNMF or medsim.

See all GeneNMF alternatives → · See all medsim alternatives →

Recent activity from GeneNMF and medsim

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 13h agomedsimmedsim 0.5.1 — fixed-branch ARIV
  2. 16d agomedsimmedsim 0.5.0 — chunked-run integrity
  3. 1mo agomedsimseed= now honored in sequential fallback paths
  4. 2mo agomedsimDocs and dependency metadata synced to the 0.2.0 state
  5. 2mo agomedsimMissing-data mediation: amputation, non-normal DGMs, D4-MBCO
  6. 3mo agomedsimv0.1.1 — cleanup release
  7. 11mo agoGeneNMFSingle-sample runs fixed; gene weight definition refined
  8. 1y agoGeneNMFMetaprogram composition exposed and custom signature DBs supported
  9. 1y agoGeneNMFSimilarity heatmap downsampling and meta-program removal
  10. 2y agoGeneNMFMeta-programs rebuilt on gene weight vectors and cosine similarity
  11. 2y agoGeneNMFFirst stable release published to CRAN

Frequently asked questions

What is the difference between GeneNMF and medsim?

They serve adjacent needs but don't currently overlap on shipped themes. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is GeneNMF better than medsim?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to GeneNMF?

Top GeneNMF alternatives in Analytics are ranked by recent ship velocity. Browse the "GeneNMF alternatives" section above for the current picks, or visit /alternatives/genenmf for the full list with editorial commentary on each.

What are the best alternatives to medsim?

Top medsim alternatives in Analytics are ranked by recent ship velocity. Browse the "medsim alternatives" section above for the current picks, or visit /alternatives/medsim for the full list with editorial commentary on each.